HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Public ClinicalTrials.gov record NCT03850795. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PROCADE: A Multinational Phase 3, Randomized, Double-Blind, Non-inferiority, Efficacy and Safety Study of Oral HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study identification
- NCT ID
- NCT03850795
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hinova Pharmaceuticals USA, Inc.
- Industry
- Enrollment
- 104 participants
Conditions and interventions
Interventions
- Enzalutamide Drug
- HC-1119 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2021
- Primary completion
- Jun 27, 2024
- Completion
- Jun 27, 2024
- Last update posted
- Aug 18, 2024
2021 – 2024
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urology Center of Colorado, 2777 Mile High Stadium Circle | Denver | Colorado | 80211 | — |
| Urologic Surgeons of Washington | Washington D.C. | District of Columbia | 20036 | — |
| First Urology PSC, 101 Hospital Boulevard | Jeffersonville | Indiana | 47130 | — |
| Clinical Research Solutions PC | Middleburg Heights | Ohio | 44130 | — |
| MidLantic Urology | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Keystone Urology Specialists | Lancaster | Pennsylvania | 17604 | — |
| Urology San Antonio Stone Oak, 18915 Meisner Drive | San Antonio | Texas | 78258-4223 | — |
| Providence Regional Cancer System | Lacey | Washington | 98503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03850795, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2024 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03850795 live on ClinicalTrials.gov.